bioAffinity Technologies, Inc. Common Stock vs. Medpace Holdings, Inc. Common Stock
BIAF
bioAffinity Technologies, Inc. Common Stock
$10.45 +58.60%
VS MEDPMedpace Holdings, Inc. Common Stock
$593.02 +1.68%
Medpace Holdings, Inc. Common Stock (MEDP) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| BIAF | MEDP | |
|---|---|---|
| Market Cap | $3.90 million | $16.28 billion |
| Revenue (TTM) | $5.90 million | $2.78 billion |
| Net Income (TTM) | $-15,185,242 | $491.50 million |
MEDP leads on 3 of 3 size & scale factors.
Valuation
| BIAF | MEDP | |
|---|---|---|
| P/E Ratio | — | 34.82 |
| Price / Book | 1.04 | 37.52 |
| Price / Sales | 0.66 | 5.85 |
BIAF leads on 2 of 2 valuation factors.
Profitability
| BIAF | MEDP | |
|---|---|---|
| Net Margin | -257.33% | 17.67% |
| Return on Equity | -402.92% | 113.29% |
MEDP leads on 2 of 2 profitability factors.
Risk & Sentiment
| BIAF | MEDP | |
|---|---|---|
| Short Interest | 1.46% | 1.35% |
MEDP leads on 1 of 1 risk & sentiment factors.
Dig deeper: BIAF overview, BIAF financials, MEDP overview, MEDP financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.